| Literature DB >> 36234787 |
Monika Prendecka-Wróbel1, Dominika Pigoń-Zając1, Magdalena Jaszek2, Anna Matuszewska2, Dawid Stefaniuk2, Grzegorz Opielak1, Katarzyna Piotrowska3, Mansur Rahnama-Hezavah4, Teresa Małecka-Massalska1.
Abstract
The increase in the incidence of cancer has contributed to the search for new therapeutic methods. In recent years, the use of preparations of natural origin from medical fungi has increased. One such active substance is the extracellular, low molecular active fraction obtained from the medicinal fungus Cerrena unicolor. This study aimed to monitor the pharmacokinetics of different concentrations of substances isolated from the medicinal fungus Cerrena unicolor (ex-LMS) using the ECIS technique. In the study, mouse L929 fibroblasts and colon cancer CT26 cell lines were treated with different concentrations of the active fractions obtained from Cerrena unicolor: C1 = 2.285 (μg/mL); C2 = 22.85 (μg/mL); and C3 = 228.5 (μg/mL). This study demonstrated that the tested preparation from Cerrena unicolor had no considerable effect on the resistance, capacitance, and impedance of L929 fibroblast cells, which was an indicator of no significant effect on its physiological processes. At the same time, those parameters exhibited a decrease in colon cancer cell viability. Following our previous and current studies on Cerrena unicolor, ex-LMS extracts can be safely used in anticancer therapy or chemoprevention with no significant harmful effects on normal cells.Entities:
Keywords: Cerrena unicolor; ECIS; anticancer properties; colon cancer; impedance; medicinal fungus
Mesh:
Year: 2022 PMID: 36234787 PMCID: PMC9571975 DOI: 10.3390/molecules27196251
Source DB: PubMed Journal: Molecules ISSN: 1420-3049 Impact factor: 4.927
IC50 values of ex-LMS on CT-26 and L929 cell lines as determined during 48 h period of MTT assay, using non-linear, four-parameter regression analysis.
| Cell Line | IC50 [µg/mL] |
|---|---|
| CT-26 | 23.6 |
| L929 | 347.5 |
Figure 1Impedance, resistance, and capacitance monitoring of the cell lines L929 (A–C) and CT-26 (A’–C’) during 80 h treatment with ex-LMS in concentration C1. The graphs show the course of impedance changes in L929 (A) and CT-26 (A’) cultures after treatment with ex-LMS at a concentration of C1 (2.28 µg/mL); resistance changes in L929 (B) and CT-26 (B’) cultures after treatment with ex-LMS at a concentration of C1 (2.28 µg/mL); and capacitance changes in L929 (C) and CT-26 (C’) cultures after treatment with ex-LMS at a concentration of C1 (2.28 µg/mL). Data are presented as mean value ± SEM.
Figure 2Impedance, resistance, and capacitance monitoring of the cell lines L929 (A–C) and CT-26 (A’–C’) during 80 h treatment with ex-LMS in concentration C2. The graphs show the course of impedance changes in L929 (A) and CT-26 (A’) cultures after treatment with ex-LMS at a concentration of C2 (22.85 µg/mL); resistance changes in L929 (B) and CT-26 (B’) cultures after treatment with ex-LMS at a concentration of C2 (22.85 µg/mL); and capacitance changes in L929 (C) and CT-26 (C’) cultures after treatment with ex-LMS at a concentration of C2 (22.85 µg/mL). Data are presented as mean value ± SEM.
Figure 3Impedance, resistance, and capacitance monitoring of the cell lines L929 (A–C) and CT-26 (A’–C’) during 80 h treatment with ex-LMS in concentration C3. The graphs show the course of impedance changes in L929 (A) and CT-26 (A’) cultures after treatment with ex-LMS at a concentration of C3 (228.5 µg/mL); resistance changes in L929 (B) and CT-26 (B’) cultures after treatment with ex-LMS at a concentration of C3 (228.5 µg/mL); and capacitance changes in L929 (C) and CT-26 (C’) cultures after treatment with ex-LMS at a concentration of C3 (228.5 µg/mL). Data are presented as mean value ± SEM.
Figure 4Influence of rotenone on the L929 cell line assessed by (a) the MTT assay and monitored by (b) the ECIS method. Data are presented as mean value ± SEM.
Number of proteins, total polysaccharides, reducing sugar, and total phenolic compound content of tested ex-LMS preparation [5].
| Preparation | Protein (µg/mL) | Total Carbohydrate (µg/mL) | Total Polysaccharides (µg/mL) | Reducin Sugars (µg/mL) | Total Phenolic (µM) |
|---|---|---|---|---|---|
| Ex-LMS | 188.97 ± 1.3 | 780.07 ± 2.7 | 272.93 ± 2.7 | 507.14 ± 2.8 | 15.0 ± 0.4 |